|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/08/23 Amneal Pharmaceuticals, Inc. 8-K12B:1,3,11/07/23 22:1.7M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: 8-K12B Notice of Securities Deemed to be Registered by a HTML 90K
Successor Issuer
2: EX-2.1 Plan of Acquisition, Reorganization, Arrangement, HTML 124K
Liquidation or Succession
3: EX-2.2 Plan of Acquisition, Reorganization, Arrangement, HTML 361K
Liquidation or Succession
4: EX-3.1 Articles of Incorporation/Organization or Bylaws HTML 67K
5: EX-3.2 Articles of Incorporation/Organization or Bylaws HTML 54K
6: EX-10.1 Material Contract HTML 11K
7: EX-10.2 Material Contract HTML 11K
8: EX-10.3 Material Contract HTML 11K
9: EX-10.4 Material Contract HTML 23K
10: EX-10.5 Material Contract HTML 250K
11: EX-10.6 Material Contract HTML 294K
12: EX-10.7 Material Contract HTML 17K
13: EX-99.1 Miscellaneous Exhibit HTML 19K
17: R1 Document and Entity Information HTML 49K
20: XML IDEA XML File -- Filing Summary XML 14K
18: XML XBRL Instance -- d454203d8k12b_htm XML 17K
19: EXCEL IDEA Workbook of Financial Report Info XLSX 8K
15: EX-101.LAB XBRL Labels -- amrx-20231107_lab XML 58K
16: EX-101.PRE XBRL Presentations -- amrx-20231107_pre XML 37K
14: EX-101.SCH XBRL Schema -- amrx-20231107 XSD 14K
21: JSON XBRL Instance as JSON Data -- MetaLinks 12± 21K
22: ZIP XBRL Zipped Folder -- 0001193125-23-272933-xbrl Zip 302K
| EX-10.3 |
Exhibit 10.3
| Re: | Elimination of UP-C Structure / Employment Agreement Amendment |
Dear Nikita:
This letter agreement is intended to memorialize our agreement and understanding regarding certain technical amendments to your employment agreement (the “Employment Agreement”) with Amneal Pharmaceuticals, Inc. (“Old Pubco”) and/or Amneal Pharmaceuticals LLC (“OpCo”) in connection with the consummation of the corporate merger transactions, effective as of the date hereof, pursuant to which we are eliminating our umbrella partnership – corporation (“UP-C”) structure.
Effective from and after the date hereof, you shall remain directly employed by OpCo, but your Employment Agreement shall be deemed amended to provide that all references therein to Old PubCo shall be deemed to instead refer to Amneal Pharmaceuticals, Inc. (f/k/a Amneal NewCo Inc.) (“New PubCo”).
Except as expressly set forth herein, all terms and conditions of your Employment Agreement shall continue in full force and effect.
| Sincerely, |
| /s/ Jason Daly |
| Jason Daly |
| Senior Vice President, Chief Legal |
| Officer and Corporate Secretary |
Agreed and Accepted:
| By: | /s/ Nikita Shah | |
| Nikita Shah |
Amneal Pharmaceuticals, 400 Crossing Blvd, Third Floor, Bridgewater, NJ 08807
P. 908.947.3120 F. 908.947.3146
| This ‘8-K12B’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 11/8/23 | |||
| For Period end: | 11/7/23 | 8-K | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/24/23 Amneal Pharmaceuticals, Inc. DEF 14A 12:7.5M Labrador Co./FA |